| laboratory practices for prenatal group b streptococcal screening and reporting--connecticut, georgia, and minnesota, 1997-1998. | group b streptococcus (gbs) is a leading cause of neonatal sepsis in the united states. cdc, in collaboration with the american college of obstetricians and gynecologists and the american academy of pediatrics, recommends that laboratories adopt optimal screening practices to identify gbs and to promptly report test results so that gbs-colonized pregnant women can receive antibiotics during labor. to assess gbs screening practices in clinical laboratories, state health departments surveyed labor ... | 1999 | 10365633 |
| prevention of perinatal group b streptococcal disease in minnesota: results from a retrospective cohort study and new prevention guidelines. | group b streptococcus (gbs) is an important cause of perinatal morbidity and mortality in the united states. in 1996, guidelines from the centers for disease control and prevention (cdc) recommended that prenatal care providers either screen all pregnant women for gbs carriage and offer intrapartum antibiotic prophylaxis (iap) to women who test positive, or offer iap to women who have risk factors for early-onset gbs (eogbs) disease during pregnancy. a recent multi-state retrospective cohort com ... | 2003 | 12959179 |